Atlas Trials

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

Clinical trial NCT00484276 · COMPLETED

Trial details

NCT number
NCT00484276
Sponsor
AGC Biologics S.p.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Mesothelioma
Start date
2007-05-01
Primary completion
2013-03-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.